PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0278678|metastatic renal cell carcinoma |
| Sentences | 1 |
| PubMedID- 23937707 | Pazopanib has been shown to have significant clinical benefit in several phase ii and iii studies in a wide variety of malignancies, including soft tissue sarcoma, thyroid cancer, ovarian cancer, non-small cell lung cancer [19-23], and in patients with metastatic renal cell carcinoma (rcc) [19,24]. |
Page: 1